| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bariatric Surgery | 22 | 2023 | 139 | 2.290 |
Why?
|
| Obesity, Morbid | 19 | 2023 | 210 | 2.030 |
Why?
|
| General Surgery | 13 | 2024 | 227 | 1.750 |
Why?
|
| Appendectomy | 10 | 2020 | 92 | 1.700 |
Why?
|
| Laparoscopy | 19 | 2020 | 523 | 1.590 |
Why?
|
| Surgeons | 8 | 2025 | 286 | 1.580 |
Why?
|
| Appendicitis | 12 | 2018 | 138 | 1.500 |
Why?
|
| Esophageal Achalasia | 3 | 2019 | 46 | 1.490 |
Why?
|
| Audiovisual Aids | 2 | 2020 | 24 | 1.210 |
Why?
|
| Enterocolitis, Necrotizing | 13 | 2015 | 248 | 1.040 |
Why?
|
| Adolescent | 96 | 2023 | 20544 | 1.010 |
Why?
|
| Child | 92 | 2022 | 25765 | 0.950 |
Why?
|
| Humans | 203 | 2025 | 132013 | 0.930 |
Why?
|
| Burnout, Professional | 7 | 2025 | 130 | 0.920 |
Why?
|
| Hernia, Inguinal | 4 | 2011 | 43 | 0.910 |
Why?
|
| Infant | 70 | 2021 | 13050 | 0.900 |
Why?
|
| Female | 149 | 2023 | 70643 | 0.840 |
Why?
|
| Catheters, Indwelling | 4 | 2018 | 157 | 0.840 |
Why?
|
| Adrenal Gland Neoplasms | 3 | 2013 | 79 | 0.830 |
Why?
|
| Bronchogenic Cyst | 2 | 2016 | 8 | 0.820 |
Why?
|
| Fundoplication | 4 | 2019 | 70 | 0.810 |
Why?
|
| Male | 135 | 2023 | 64914 | 0.790 |
Why?
|
| Retrospective Studies | 64 | 2022 | 17374 | 0.790 |
Why?
|
| Gastrostomy | 5 | 2019 | 92 | 0.780 |
Why?
|
| Gastric Bypass | 9 | 2019 | 80 | 0.770 |
Why?
|
| Specialties, Surgical | 4 | 2020 | 91 | 0.750 |
Why?
|
| Hospitals, Pediatric | 9 | 2022 | 777 | 0.740 |
Why?
|
| Peritoneal Dialysis | 3 | 2018 | 137 | 0.730 |
Why?
|
| Esophageal Diseases | 2 | 2016 | 37 | 0.730 |
Why?
|
| Computer-Assisted Instruction | 2 | 2012 | 53 | 0.730 |
Why?
|
| Quality of Life | 11 | 2022 | 2157 | 0.730 |
Why?
|
| Informed Consent | 4 | 2024 | 346 | 0.720 |
Why?
|
| Umbilicus | 2 | 2013 | 14 | 0.710 |
Why?
|
| Postoperative Complications | 26 | 2018 | 3137 | 0.710 |
Why?
|
| Internet | 3 | 2012 | 406 | 0.680 |
Why?
|
| Vulnerable Populations | 1 | 2022 | 147 | 0.660 |
Why?
|
| Cholestasis, Intrahepatic | 2 | 2018 | 58 | 0.660 |
Why?
|
| Child, Preschool | 58 | 2021 | 14736 | 0.660 |
Why?
|
| Breast | 3 | 2013 | 215 | 0.640 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2012 | 159 | 0.640 |
Why?
|
| Educational Measurement | 4 | 2015 | 329 | 0.630 |
Why?
|
| Lipoblastoma | 3 | 2016 | 6 | 0.620 |
Why?
|
| Kidney Failure, Chronic | 5 | 2018 | 950 | 0.610 |
Why?
|
| Heller Myotomy | 1 | 2019 | 7 | 0.610 |
Why?
|
| Colostomy | 1 | 2019 | 28 | 0.600 |
Why?
|
| Thoracic Surgery, Video-Assisted | 3 | 2014 | 56 | 0.600 |
Why?
|
| Manometry | 1 | 2019 | 72 | 0.590 |
Why?
|
| Weight Loss | 15 | 2023 | 515 | 0.590 |
Why?
|
| Job Satisfaction | 3 | 2021 | 99 | 0.590 |
Why?
|
| Biliary Atresia | 7 | 2020 | 206 | 0.590 |
Why?
|
| Preoperative Care | 5 | 2019 | 367 | 0.590 |
Why?
|
| Parental Consent | 2 | 2018 | 22 | 0.590 |
Why?
|
| Pediatric Obesity | 7 | 2018 | 415 | 0.570 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2018 | 23 | 0.560 |
Why?
|
| Laparotomy | 5 | 2013 | 144 | 0.560 |
Why?
|
| Intestinal Obstruction | 6 | 2019 | 96 | 0.550 |
Why?
|
| Alagille Syndrome | 1 | 2018 | 48 | 0.540 |
Why?
|
| Inguinal Canal | 2 | 2014 | 13 | 0.540 |
Why?
|
| Software | 2 | 2012 | 731 | 0.530 |
Why?
|
| Intestinal Perforation | 5 | 2013 | 56 | 0.520 |
Why?
|
| Liver Transplantation | 10 | 2020 | 1103 | 0.520 |
Why?
|
| Infant, Newborn | 39 | 2021 | 8542 | 0.520 |
Why?
|
| Internship and Residency | 7 | 2024 | 1256 | 0.520 |
Why?
|
| Adrenal Medulla | 2 | 2013 | 8 | 0.510 |
Why?
|
| Patient Education as Topic | 2 | 2020 | 465 | 0.510 |
Why?
|
| Esophagogastric Junction | 1 | 2016 | 34 | 0.510 |
Why?
|
| Students, Medical | 4 | 2015 | 363 | 0.510 |
Why?
|
| Peritoneum | 3 | 2016 | 41 | 0.510 |
Why?
|
| Breast Diseases | 2 | 2006 | 38 | 0.510 |
Why?
|
| Health Education | 1 | 2018 | 235 | 0.500 |
Why?
|
| Pediatrics | 8 | 2024 | 1211 | 0.500 |
Why?
|
| Fibroadenoma | 2 | 2013 | 9 | 0.490 |
Why?
|
| Intestine, Small | 5 | 2019 | 309 | 0.490 |
Why?
|
| Intubation, Gastrointestinal | 3 | 2019 | 55 | 0.490 |
Why?
|
| Health Resources | 2 | 2014 | 135 | 0.480 |
Why?
|
| Attitude of Health Personnel | 2 | 2020 | 726 | 0.470 |
Why?
|
| Cysts | 2 | 2013 | 97 | 0.460 |
Why?
|
| Ovary | 2 | 2016 | 369 | 0.460 |
Why?
|
| Pylorus | 3 | 2008 | 21 | 0.460 |
Why?
|
| Enteral Nutrition | 5 | 2019 | 267 | 0.460 |
Why?
|
| Curriculum | 5 | 2015 | 767 | 0.440 |
Why?
|
| Catheterization | 1 | 2016 | 241 | 0.440 |
Why?
|
| Follow-Up Studies | 20 | 2020 | 5409 | 0.430 |
Why?
|
| Ovarian Cysts | 3 | 2014 | 23 | 0.430 |
Why?
|
| Body Mass Index | 16 | 2020 | 1697 | 0.430 |
Why?
|
| Antivenins | 1 | 2014 | 13 | 0.430 |
Why?
|
| Social Welfare | 1 | 2013 | 7 | 0.420 |
Why?
|
| Snake Bites | 1 | 2014 | 17 | 0.420 |
Why?
|
| Volunteers | 1 | 2013 | 25 | 0.420 |
Why?
|
| Critical Care | 2 | 2011 | 686 | 0.420 |
Why?
|
| Pheochromocytoma | 2 | 2013 | 38 | 0.420 |
Why?
|
| Adrenal Insufficiency | 1 | 2014 | 31 | 0.420 |
Why?
|
| Pilomatrixoma | 1 | 2013 | 4 | 0.410 |
Why?
|
| Hair Diseases | 1 | 2013 | 12 | 0.410 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2013 | 20 | 0.400 |
Why?
|
| Hemangioendothelioma | 1 | 2013 | 25 | 0.400 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2013 | 16 | 0.400 |
Why?
|
| Liver Diseases | 5 | 2013 | 385 | 0.400 |
Why?
|
| Treatment Outcome | 32 | 2020 | 12987 | 0.400 |
Why?
|
| Duodenum | 2 | 2013 | 113 | 0.390 |
Why?
|
| Surgical Procedures, Operative | 3 | 2016 | 223 | 0.390 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2012 | 31 | 0.380 |
Why?
|
| Cicatrix | 1 | 2013 | 121 | 0.380 |
Why?
|
| Portoenterostomy, Hepatic | 4 | 2020 | 60 | 0.380 |
Why?
|
| Puberty, Precocious | 2 | 2012 | 29 | 0.380 |
Why?
|
| Drug Implants | 1 | 2012 | 45 | 0.370 |
Why?
|
| Young Adult | 24 | 2022 | 9952 | 0.360 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2020 | 1411 | 0.360 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2012 | 77 | 0.360 |
Why?
|
| Burkitt Lymphoma | 1 | 2013 | 141 | 0.360 |
Why?
|
| Education, Medical, Graduate | 4 | 2024 | 564 | 0.350 |
Why?
|
| Histocytochemistry | 1 | 2011 | 92 | 0.350 |
Why?
|
| Child Development | 1 | 2013 | 271 | 0.340 |
Why?
|
| Fungi | 1 | 2011 | 76 | 0.330 |
Why?
|
| Surveys and Questionnaires | 13 | 2024 | 3993 | 0.330 |
Why?
|
| Risk Factors | 23 | 2020 | 10931 | 0.330 |
Why?
|
| Intensive Care Units | 2 | 2020 | 523 | 0.330 |
Why?
|
| Ultrasonography | 8 | 2021 | 984 | 0.320 |
Why?
|
| Disease Management | 1 | 2014 | 562 | 0.320 |
Why?
|
| Mycoses | 1 | 2011 | 117 | 0.320 |
Why?
|
| Diagnosis, Differential | 12 | 2019 | 1957 | 0.310 |
Why?
|
| Breast Neoplasms | 3 | 2013 | 2647 | 0.310 |
Why?
|
| Teaching | 2 | 2012 | 201 | 0.310 |
Why?
|
| Sepsis | 4 | 2015 | 515 | 0.300 |
Why?
|
| Gastroplasty | 3 | 2020 | 12 | 0.300 |
Why?
|
| United States | 23 | 2025 | 11655 | 0.300 |
Why?
|
| Time Factors | 15 | 2020 | 6441 | 0.290 |
Why?
|
| Bilirubin | 3 | 2020 | 128 | 0.290 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2008 | 6 | 0.290 |
Why?
|
| Prospective Studies | 20 | 2023 | 6568 | 0.290 |
Why?
|
| Radiography, Abdominal | 3 | 2019 | 49 | 0.290 |
Why?
|
| Mediastinal Cyst | 1 | 2008 | 10 | 0.290 |
Why?
|
| Gastroesophageal Reflux | 5 | 2019 | 338 | 0.280 |
Why?
|
| Abdomen | 3 | 2015 | 135 | 0.280 |
Why?
|
| Neonatal Screening | 3 | 2020 | 192 | 0.280 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 3 | 2023 | 420 | 0.280 |
Why?
|
| Hyperbilirubinemia | 1 | 2008 | 42 | 0.280 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2013 | 1009 | 0.280 |
Why?
|
| Patient Care Team | 2 | 2013 | 572 | 0.270 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2016 | 1305 | 0.270 |
Why?
|
| Anus, Imperforate | 1 | 2007 | 20 | 0.270 |
Why?
|
| Anti-Bacterial Agents | 5 | 2014 | 2554 | 0.270 |
Why?
|
| Academic Medical Centers | 2 | 2013 | 333 | 0.270 |
Why?
|
| Competency-Based Education | 1 | 2008 | 80 | 0.260 |
Why?
|
| Severity of Illness Index | 8 | 2019 | 3088 | 0.260 |
Why?
|
| Body Weight | 3 | 2016 | 994 | 0.260 |
Why?
|
| Incidence | 13 | 2020 | 3375 | 0.260 |
Why?
|
| Fecal Incontinence | 1 | 2007 | 78 | 0.260 |
Why?
|
| Workload | 2 | 2013 | 151 | 0.250 |
Why?
|
| Sensitivity and Specificity | 14 | 2021 | 2139 | 0.250 |
Why?
|
| Insurance Coverage | 2 | 2020 | 127 | 0.250 |
Why?
|
| Infant, Premature, Diseases | 6 | 2014 | 252 | 0.250 |
Why?
|
| Age Factors | 10 | 2020 | 2911 | 0.240 |
Why?
|
| Hernia, Obturator | 1 | 2005 | 5 | 0.240 |
Why?
|
| Soft Tissue Neoplasms | 2 | 2013 | 127 | 0.240 |
Why?
|
| Quality Improvement | 3 | 2020 | 699 | 0.240 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 896 | 0.240 |
Why?
|
| Cell Transplantation | 2 | 1996 | 42 | 0.240 |
Why?
|
| Fibrinogen | 3 | 2015 | 157 | 0.230 |
Why?
|
| Adult | 32 | 2022 | 31563 | 0.230 |
Why?
|
| Abscess | 1 | 2006 | 140 | 0.230 |
Why?
|
| Reference Values | 4 | 2020 | 703 | 0.230 |
Why?
|
| Logistic Models | 8 | 2018 | 1839 | 0.230 |
Why?
|
| Staphylococcal Infections | 2 | 2004 | 569 | 0.230 |
Why?
|
| Obesity | 9 | 2014 | 2397 | 0.230 |
Why?
|
| Renal Insufficiency | 1 | 2007 | 256 | 0.220 |
Why?
|
| Morals | 1 | 2025 | 73 | 0.220 |
Why?
|
| Fetus | 2 | 1999 | 589 | 0.220 |
Why?
|
| Reoperation | 7 | 2019 | 852 | 0.220 |
Why?
|
| Length of Stay | 9 | 2020 | 1380 | 0.220 |
Why?
|
| Empyema, Pleural | 1 | 2004 | 26 | 0.220 |
Why?
|
| Middle Aged | 18 | 2020 | 28968 | 0.210 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2015 | 153 | 0.210 |
Why?
|
| Wounds and Injuries | 3 | 2020 | 393 | 0.210 |
Why?
|
| Meningitis, Fungal | 2 | 2013 | 6 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2015 | 2164 | 0.200 |
Why?
|
| Drug Contamination | 2 | 2013 | 38 | 0.200 |
Why?
|
| Risk Assessment | 8 | 2020 | 3731 | 0.200 |
Why?
|
| Health Status | 2 | 2022 | 407 | 0.200 |
Why?
|
| Clinical Competence | 3 | 2016 | 1074 | 0.200 |
Why?
|
| Prenatal Diagnosis | 3 | 2018 | 631 | 0.200 |
Why?
|
| Health Policy | 1 | 2025 | 233 | 0.200 |
Why?
|
| Intestinal Diseases | 2 | 2011 | 76 | 0.200 |
Why?
|
| Acute Disease | 7 | 2018 | 1160 | 0.200 |
Why?
|
| Methylprednisolone | 2 | 2013 | 98 | 0.200 |
Why?
|
| Thrombocytopenia | 1 | 2005 | 233 | 0.200 |
Why?
|
| Peer Group | 1 | 2024 | 121 | 0.200 |
Why?
|
| Critical Pathways | 2 | 2013 | 75 | 0.190 |
Why?
|
| Texas | 8 | 2014 | 3627 | 0.190 |
Why?
|
| Hospital Mortality | 1 | 2007 | 1057 | 0.190 |
Why?
|
| Tuberculosis, Gastrointestinal | 1 | 2002 | 7 | 0.190 |
Why?
|
| Drainage | 3 | 2006 | 262 | 0.190 |
Why?
|
| Endoscopy | 2 | 2016 | 288 | 0.180 |
Why?
|
| Pneumococcal Infections | 1 | 2004 | 277 | 0.180 |
Why?
|
| Thyroid Neoplasms | 2 | 2013 | 251 | 0.180 |
Why?
|
| Parovarian Cyst | 2 | 2011 | 11 | 0.180 |
Why?
|
| Cholecystectomy | 2 | 2011 | 64 | 0.180 |
Why?
|
| Radiography | 4 | 2014 | 819 | 0.180 |
Why?
|
| Feeding and Eating Disorders | 2 | 2019 | 76 | 0.180 |
Why?
|
| Ovarian Neoplasms | 3 | 2016 | 462 | 0.180 |
Why?
|
| Surgical Wound Infection | 3 | 2020 | 272 | 0.180 |
Why?
|
| Thyroidectomy | 3 | 2017 | 102 | 0.180 |
Why?
|
| Disease Outbreaks | 2 | 2013 | 329 | 0.170 |
Why?
|
| Gastrectomy | 3 | 2019 | 102 | 0.170 |
Why?
|
| Aged, 80 and over | 9 | 2016 | 7105 | 0.170 |
Why?
|
| Liver | 8 | 2015 | 1798 | 0.170 |
Why?
|
| Compassion Fatigue | 1 | 2021 | 10 | 0.170 |
Why?
|
| Lipomatosis | 1 | 2001 | 16 | 0.170 |
Why?
|
| Lipoma | 1 | 2001 | 26 | 0.170 |
Why?
|
| Intestinal Volvulus | 1 | 2021 | 40 | 0.170 |
Why?
|
| Cardiovascular Diseases | 4 | 2018 | 2088 | 0.170 |
Why?
|
| Digestive System Abnormalities | 1 | 2021 | 40 | 0.170 |
Why?
|
| Choledocholithiasis | 1 | 2020 | 14 | 0.170 |
Why?
|
| Cholelithiasis | 1 | 2000 | 18 | 0.170 |
Why?
|
| Glucocorticoids | 2 | 2013 | 386 | 0.170 |
Why?
|
| Clothing | 1 | 2020 | 12 | 0.160 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2020 | 43 | 0.160 |
Why?
|
| Chemoprevention | 1 | 2020 | 53 | 0.160 |
Why?
|
| Cooperative Behavior | 2 | 2013 | 232 | 0.160 |
Why?
|
| Authorship | 1 | 2020 | 29 | 0.160 |
Why?
|
| Sexism | 1 | 2020 | 43 | 0.160 |
Why?
|
| Wounds, Nonpenetrating | 4 | 2004 | 221 | 0.160 |
Why?
|
| Incidental Findings | 2 | 2013 | 130 | 0.160 |
Why?
|
| Ileostomy | 1 | 2000 | 32 | 0.160 |
Why?
|
| Tissue Adhesions | 1 | 2019 | 29 | 0.160 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2020 | 36 | 0.160 |
Why?
|
| beta-Galactosidase | 1 | 1999 | 139 | 0.160 |
Why?
|
| Predictive Value of Tests | 9 | 2020 | 2311 | 0.160 |
Why?
|
| Pyloric Stenosis | 1 | 1999 | 10 | 0.160 |
Why?
|
| Longitudinal Studies | 7 | 2018 | 1500 | 0.160 |
Why?
|
| Operating Rooms | 1 | 2020 | 79 | 0.160 |
Why?
|
| Conservative Treatment | 1 | 2019 | 41 | 0.150 |
Why?
|
| Postoperative Care | 2 | 1999 | 312 | 0.150 |
Why?
|
| Head | 1 | 2020 | 115 | 0.150 |
Why?
|
| Feeding Methods | 1 | 1999 | 37 | 0.150 |
Why?
|
| CD40 Antigens | 1 | 2019 | 27 | 0.150 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 1439 | 0.150 |
Why?
|
| Anorectal Malformations | 1 | 2019 | 15 | 0.150 |
Why?
|
| Urinary Incontinence | 2 | 2017 | 78 | 0.150 |
Why?
|
| Problem-Based Learning | 2 | 2012 | 73 | 0.150 |
Why?
|
| Trauma Centers | 1 | 2020 | 199 | 0.150 |
Why?
|
| Gene Transfer Techniques | 2 | 1999 | 347 | 0.150 |
Why?
|
| Prognosis | 9 | 2023 | 5008 | 0.150 |
Why?
|
| Time Management | 1 | 2018 | 12 | 0.140 |
Why?
|
| Intestines | 3 | 2014 | 606 | 0.140 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2018 | 30 | 0.140 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2019 | 100 | 0.140 |
Why?
|
| Health Care Costs | 2 | 2012 | 415 | 0.140 |
Why?
|
| Kidney | 3 | 2014 | 1329 | 0.140 |
Why?
|
| Algorithms | 3 | 2014 | 1718 | 0.140 |
Why?
|
| Infant, Premature | 7 | 2014 | 843 | 0.140 |
Why?
|
| Urologic Surgical Procedures | 1 | 2018 | 62 | 0.140 |
Why?
|
| Antifungal Agents | 4 | 2013 | 314 | 0.140 |
Why?
|
| Aged | 14 | 2017 | 21406 | 0.140 |
Why?
|
| Comprehension | 1 | 2018 | 81 | 0.140 |
Why?
|
| Visceral Prolapse | 1 | 2017 | 2 | 0.140 |
Why?
|
| Odds Ratio | 5 | 2017 | 1254 | 0.140 |
Why?
|
| Anesthesia | 1 | 2020 | 216 | 0.140 |
Why?
|
| Accidents, Occupational | 1 | 2017 | 9 | 0.140 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 185 | 0.130 |
Why?
|
| Early Diagnosis | 1 | 2018 | 195 | 0.130 |
Why?
|
| Anesthesia, General | 1 | 2018 | 124 | 0.130 |
Why?
|
| Enterohepatic Circulation | 1 | 2017 | 11 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2021 | 3843 | 0.130 |
Why?
|
| Leadership | 2 | 2011 | 247 | 0.130 |
Why?
|
| Cystic Fibrosis | 1 | 2000 | 264 | 0.130 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 237 | 0.130 |
Why?
|
| Educational Status | 1 | 2018 | 294 | 0.130 |
Why?
|
| Career Mobility | 1 | 2017 | 52 | 0.130 |
Why?
|
| Needles | 1 | 1997 | 53 | 0.130 |
Why?
|
| Occupational Diseases | 1 | 2017 | 74 | 0.130 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 133 | 0.130 |
Why?
|
| Hypocalcemia | 1 | 2017 | 38 | 0.130 |
Why?
|
| Pneumothorax | 2 | 2014 | 83 | 0.130 |
Why?
|
| Biomarkers | 6 | 2016 | 3402 | 0.130 |
Why?
|
| Transplantation, Heterotopic | 1 | 1996 | 27 | 0.130 |
Why?
|
| Portal System | 1 | 1996 | 36 | 0.120 |
Why?
|
| Vulvar Neoplasms | 1 | 2016 | 22 | 0.120 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2017 | 88 | 0.120 |
Why?
|
| Thyroid Gland | 2 | 2013 | 104 | 0.120 |
Why?
|
| Gastric Mucosa | 2 | 2017 | 491 | 0.120 |
Why?
|
| Feeding Behavior | 2 | 2022 | 721 | 0.120 |
Why?
|
| Pyriform Sinus | 1 | 2016 | 8 | 0.120 |
Why?
|
| Jejunostomy | 2 | 2017 | 22 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 4 | 2013 | 1554 | 0.120 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 448 | 0.120 |
Why?
|
| Cohort Studies | 9 | 2019 | 5166 | 0.120 |
Why?
|
| Thyroid Diseases | 1 | 2016 | 29 | 0.120 |
Why?
|
| Diseases in Twins | 2 | 2013 | 97 | 0.120 |
Why?
|
| Confidence Intervals | 3 | 2017 | 277 | 0.120 |
Why?
|
| Twins, Monozygotic | 2 | 2013 | 127 | 0.120 |
Why?
|
| Carcinoma, Papillary | 1 | 1996 | 94 | 0.120 |
Why?
|
| Organ Sparing Treatments | 1 | 2016 | 43 | 0.120 |
Why?
|
| Factor XIII | 1 | 2015 | 7 | 0.120 |
Why?
|
| Career Choice | 1 | 2017 | 159 | 0.120 |
Why?
|
| Certification | 1 | 2016 | 72 | 0.120 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 294 | 0.120 |
Why?
|
| Fistula | 1 | 2016 | 53 | 0.120 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2016 | 128 | 0.120 |
Why?
|
| Prevalence | 5 | 2015 | 2655 | 0.120 |
Why?
|
| Genetic Therapy | 2 | 1999 | 720 | 0.120 |
Why?
|
| Empathy | 2 | 2021 | 64 | 0.120 |
Why?
|
| Anticoagulants | 1 | 2020 | 606 | 0.120 |
Why?
|
| Health Care Surveys | 2 | 2013 | 294 | 0.120 |
Why?
|
| Meckel Diverticulum | 2 | 2013 | 11 | 0.120 |
Why?
|
| Thoracostomy | 2 | 2014 | 27 | 0.120 |
Why?
|
| Eating | 1 | 2017 | 381 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 499 | 0.120 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2015 | 33 | 0.120 |
Why?
|
| Musculoskeletal Pain | 1 | 2015 | 16 | 0.120 |
Why?
|
| Spleen | 1 | 1996 | 271 | 0.110 |
Why?
|
| Intussusception | 2 | 2013 | 55 | 0.110 |
Why?
|
| Y Chromosome | 1 | 1995 | 47 | 0.110 |
Why?
|
| Caregivers | 2 | 2013 | 588 | 0.110 |
Why?
|
| Escherichia coli Infections | 2 | 2013 | 192 | 0.110 |
Why?
|
| Gastrointestinal Hormones | 2 | 2015 | 21 | 0.110 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2008 | 96 | 0.110 |
Why?
|
| Cryptococcosis | 2 | 2006 | 45 | 0.110 |
Why?
|
| Choristoma | 2 | 2011 | 46 | 0.110 |
Why?
|
| Pleurodesis | 1 | 2014 | 15 | 0.110 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2014 | 20 | 0.110 |
Why?
|
| Wounds, Penetrating | 3 | 1993 | 142 | 0.110 |
Why?
|
| Stomach | 1 | 1997 | 273 | 0.110 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1995 | 70 | 0.110 |
Why?
|
| Splanchnic Circulation | 1 | 2014 | 51 | 0.110 |
Why?
|
| Cross-Sectional Studies | 6 | 2021 | 3760 | 0.110 |
Why?
|
| Infant, Very Low Birth Weight | 3 | 2008 | 176 | 0.110 |
Why?
|
| In Situ Hybridization | 2 | 2011 | 469 | 0.110 |
Why?
|
| Blood Glucose | 3 | 2018 | 1121 | 0.110 |
Why?
|
| Candidiasis | 2 | 2004 | 137 | 0.110 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2006 | 138 | 0.110 |
Why?
|
| Liver Abscess | 1 | 1994 | 13 | 0.110 |
Why?
|
| Medical Errors | 3 | 2024 | 161 | 0.110 |
Why?
|
| Uterus | 2 | 2014 | 548 | 0.110 |
Why?
|
| Bariatric Medicine | 1 | 2013 | 1 | 0.110 |
Why?
|
| Arachnoiditis | 1 | 2013 | 2 | 0.110 |
Why?
|
| Chest Tubes | 1 | 1994 | 37 | 0.110 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2011 | 75 | 0.110 |
Why?
|
| Unnecessary Procedures | 1 | 2014 | 60 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2016 | 1011 | 0.100 |
Why?
|
| Faculty, Medical | 1 | 2017 | 277 | 0.100 |
Why?
|
| Pleural Diseases | 1 | 1994 | 31 | 0.100 |
Why?
|
| Esophageal Atresia | 1 | 2014 | 52 | 0.100 |
Why?
|
| Enema | 2 | 2013 | 44 | 0.100 |
Why?
|
| Adolescent Health Services | 1 | 2013 | 34 | 0.100 |
Why?
|
| Emergency Service, Hospital | 2 | 2019 | 1168 | 0.100 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2014 | 93 | 0.100 |
Why?
|
| Disease Susceptibility | 3 | 2011 | 293 | 0.100 |
Why?
|
| Decision Making | 2 | 2020 | 700 | 0.100 |
Why?
|
| Bezoars | 1 | 2013 | 5 | 0.100 |
Why?
|
| Awareness | 1 | 2013 | 80 | 0.100 |
Why?
|
| Psychology, Child | 1 | 2013 | 44 | 0.100 |
Why?
|
| Survival Analysis | 4 | 2011 | 1572 | 0.100 |
Why?
|
| Personal Satisfaction | 3 | 2021 | 106 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 271 | 0.100 |
Why?
|
| Gestational Age | 5 | 2018 | 1226 | 0.100 |
Why?
|
| Mucorales | 1 | 2012 | 2 | 0.100 |
Why?
|
| Catheter Ablation | 1 | 2016 | 258 | 0.100 |
Why?
|
| Tornadoes | 1 | 2012 | 3 | 0.100 |
Why?
|
| Patient Handoff | 1 | 2013 | 24 | 0.100 |
Why?
|
| Trichotillomania | 1 | 2013 | 34 | 0.100 |
Why?
|
| Chronic Pain | 1 | 2015 | 149 | 0.100 |
Why?
|
| Suture Techniques | 2 | 2013 | 189 | 0.100 |
Why?
|
| Dermatomycoses | 1 | 2012 | 18 | 0.100 |
Why?
|
| Comorbidity | 6 | 2016 | 1604 | 0.100 |
Why?
|
| Immunohistochemistry | 3 | 2011 | 1710 | 0.100 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2012 | 30 | 0.100 |
Why?
|
| Parents | 1 | 2020 | 1079 | 0.100 |
Why?
|
| Schools, Medical | 1 | 2013 | 121 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 4 | 2013 | 1300 | 0.100 |
Why?
|
| Sex Factors | 3 | 2018 | 1351 | 0.100 |
Why?
|
| Mucormycosis | 1 | 2012 | 32 | 0.100 |
Why?
|
| Meconium | 2 | 2004 | 12 | 0.100 |
Why?
|
| Urogenital Abnormalities | 1 | 2014 | 164 | 0.090 |
Why?
|
| Evidence-Based Practice | 1 | 2013 | 115 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2017 | 575 | 0.090 |
Why?
|
| Siblings | 1 | 2013 | 202 | 0.090 |
Why?
|
| Splenectomy | 1 | 2012 | 62 | 0.090 |
Why?
|
| Remission Induction | 2 | 2019 | 306 | 0.090 |
Why?
|
| Platelet Count | 3 | 2012 | 139 | 0.090 |
Why?
|
| Disaster Planning | 1 | 2012 | 63 | 0.090 |
Why?
|
| End Stage Liver Disease | 1 | 2014 | 191 | 0.090 |
Why?
|
| Motor Activity | 1 | 2015 | 523 | 0.090 |
Why?
|
| Short Bowel Syndrome | 2 | 2010 | 66 | 0.090 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2012 | 54 | 0.090 |
Why?
|
| Administration, Cutaneous | 1 | 2012 | 67 | 0.090 |
Why?
|
| Gallbladder Diseases | 1 | 2011 | 26 | 0.090 |
Why?
|
| Disorders of Sex Development | 1 | 2012 | 71 | 0.090 |
Why?
|
| Soft Tissue Infections | 1 | 2012 | 91 | 0.090 |
Why?
|
| Hyperandrogenism | 1 | 2011 | 25 | 0.090 |
Why?
|
| Combined Modality Therapy | 4 | 2012 | 1294 | 0.090 |
Why?
|
| Disease Progression | 1 | 2018 | 2226 | 0.090 |
Why?
|
| Pain Management | 1 | 2013 | 196 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 310 | 0.090 |
Why?
|
| Stomach Diseases | 1 | 2011 | 56 | 0.090 |
Why?
|
| Ligation | 3 | 2008 | 139 | 0.090 |
Why?
|
| Herniorrhaphy | 1 | 2011 | 78 | 0.090 |
Why?
|
| Diaphragm | 1 | 1992 | 98 | 0.090 |
Why?
|
| Pancreas | 2 | 2011 | 222 | 0.090 |
Why?
|
| Age Distribution | 3 | 2015 | 438 | 0.090 |
Why?
|
| Pregnancy | 8 | 2018 | 7554 | 0.090 |
Why?
|
| Oxygen | 1 | 2014 | 569 | 0.090 |
Why?
|
| Physician-Patient Relations | 2 | 2025 | 448 | 0.090 |
Why?
|
| Pathology, Molecular | 1 | 2011 | 67 | 0.080 |
Why?
|
| Evidence-Based Medicine | 2 | 2013 | 662 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 570 | 0.080 |
Why?
|
| Emergency Medicine | 1 | 2012 | 163 | 0.080 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 1990 | 35 | 0.080 |
Why?
|
| Pancreatectomy | 1 | 2011 | 149 | 0.080 |
Why?
|
| Infant, Low Birth Weight | 3 | 2008 | 174 | 0.080 |
Why?
|
| Pain, Postoperative | 1 | 2013 | 273 | 0.080 |
Why?
|
| Fetal Diseases | 2 | 1992 | 461 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2010 | 64 | 0.080 |
Why?
|
| Carcinoma, Small Cell | 1 | 2010 | 42 | 0.080 |
Why?
|
| Abdominal Neoplasms | 1 | 2010 | 31 | 0.080 |
Why?
|
| Michigan | 2 | 2007 | 50 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 1340 | 0.080 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2010 | 234 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2015 | 785 | 0.080 |
Why?
|
| Down Syndrome | 1 | 2013 | 231 | 0.080 |
Why?
|
| Peptides | 1 | 2013 | 846 | 0.080 |
Why?
|
| Alanine Transaminase | 2 | 2023 | 162 | 0.080 |
Why?
|
| Interpersonal Relations | 2 | 2008 | 233 | 0.080 |
Why?
|
| Parenteral Nutrition | 1 | 2011 | 199 | 0.080 |
Why?
|
| Chromosomes, Human, X | 1 | 2010 | 157 | 0.080 |
Why?
|
| Shock, Septic | 1 | 2011 | 155 | 0.080 |
Why?
|
| Granulosa Cell Tumor | 1 | 2009 | 38 | 0.080 |
Why?
|
| Rabbits | 3 | 1999 | 673 | 0.080 |
Why?
|
| Patient Discharge | 1 | 2013 | 512 | 0.070 |
Why?
|
| Subcutaneous Tissue | 1 | 2008 | 15 | 0.070 |
Why?
|
| Creatinine | 2 | 2008 | 412 | 0.070 |
Why?
|
| Biopsy, Needle | 2 | 2002 | 234 | 0.070 |
Why?
|
| Consensus | 1 | 2012 | 649 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 669 | 0.070 |
Why?
|
| Sternum | 1 | 2008 | 53 | 0.070 |
Why?
|
| Fatty Liver | 1 | 2010 | 211 | 0.070 |
Why?
|
| Renal Dialysis | 2 | 2008 | 947 | 0.070 |
Why?
|
| Immunocompromised Host | 2 | 2012 | 307 | 0.070 |
Why?
|
| Stroke | 2 | 2013 | 1081 | 0.070 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2009 | 194 | 0.070 |
Why?
|
| Intracranial Hypertension | 1 | 2010 | 133 | 0.070 |
Why?
|
| ROC Curve | 3 | 2015 | 600 | 0.070 |
Why?
|
| Paraganglioma | 1 | 2007 | 24 | 0.070 |
Why?
|
| Syndrome | 2 | 2013 | 1174 | 0.070 |
Why?
|
| Accreditation | 1 | 2008 | 94 | 0.070 |
Why?
|
| Enuresis | 1 | 2007 | 6 | 0.070 |
Why?
|
| Models, Educational | 1 | 2008 | 76 | 0.070 |
Why?
|
| Population Surveillance | 3 | 2006 | 416 | 0.070 |
Why?
|
| Social Change | 1 | 2007 | 15 | 0.070 |
Why?
|
| Motivation | 1 | 2010 | 330 | 0.070 |
Why?
|
| Ganglion Cysts | 1 | 2007 | 3 | 0.070 |
Why?
|
| Temporomandibular Joint | 1 | 2007 | 10 | 0.070 |
Why?
|
| Program Evaluation | 2 | 2024 | 453 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2013 | 767 | 0.070 |
Why?
|
| Wrist Joint | 1 | 2007 | 28 | 0.070 |
Why?
|
| Genetic Vectors | 4 | 1999 | 927 | 0.070 |
Why?
|
| HIV Seroprevalence | 1 | 2006 | 8 | 0.070 |
Why?
|
| Leukocyte Count | 2 | 2005 | 249 | 0.070 |
Why?
|
| Catheterization, Central Venous | 1 | 2008 | 139 | 0.060 |
Why?
|
| Ankle Joint | 1 | 2007 | 35 | 0.060 |
Why?
|
| Gallstones | 2 | 2011 | 20 | 0.060 |
Why?
|
| Professional Competence | 1 | 2007 | 95 | 0.060 |
Why?
|
| Abdominal Pain | 3 | 2005 | 314 | 0.060 |
Why?
|
| Anxiety | 1 | 2013 | 991 | 0.060 |
Why?
|
| Postoperative Period | 2 | 2017 | 334 | 0.060 |
Why?
|
| Duodenal Diseases | 2 | 1986 | 34 | 0.060 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2008 | 144 | 0.060 |
Why?
|
| Vascular Surgical Procedures | 2 | 2008 | 552 | 0.060 |
Why?
|
| Self Concept | 1 | 2007 | 164 | 0.060 |
Why?
|
| Ovariectomy | 2 | 2009 | 169 | 0.060 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2008 | 373 | 0.060 |
Why?
|
| Rupture, Spontaneous | 1 | 2005 | 47 | 0.060 |
Why?
|
| Cause of Death | 1 | 2008 | 510 | 0.060 |
Why?
|
| Malabsorption Syndromes | 1 | 1985 | 29 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 3008 | 0.060 |
Why?
|
| Time-to-Treatment | 2 | 2020 | 210 | 0.060 |
Why?
|
| Triglycerides | 2 | 2023 | 617 | 0.060 |
Why?
|
| Histamine H2 Antagonists | 1 | 2005 | 49 | 0.060 |
Why?
|
| Platelet Transfusion | 1 | 2005 | 56 | 0.060 |
Why?
|
| Animals | 11 | 2019 | 34804 | 0.060 |
Why?
|
| Societies, Medical | 2 | 2024 | 778 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 1127 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 4684 | 0.050 |
Why?
|
| Peptic Ulcer | 1 | 2005 | 150 | 0.050 |
Why?
|
| Fungemia | 1 | 2004 | 23 | 0.050 |
Why?
|
| Thoracic Arteries | 1 | 2004 | 5 | 0.050 |
Why?
|
| Genetic Markers | 2 | 1999 | 618 | 0.050 |
Why?
|
| Family | 1 | 2007 | 595 | 0.050 |
Why?
|
| Area Under Curve | 2 | 2015 | 321 | 0.050 |
Why?
|
| Pulmonary Surfactants | 1 | 2004 | 46 | 0.050 |
Why?
|
| Abdominal Wall | 1 | 2004 | 26 | 0.050 |
Why?
|
| C-Reactive Protein | 2 | 2018 | 464 | 0.050 |
Why?
|
| Diarrhea | 1 | 1985 | 331 | 0.050 |
Why?
|
| Exercise | 1 | 2009 | 858 | 0.050 |
Why?
|
| Elective Surgical Procedures | 2 | 2005 | 161 | 0.050 |
Why?
|
| Fluorocarbons | 1 | 2004 | 58 | 0.050 |
Why?
|
| Candida | 1 | 2004 | 84 | 0.050 |
Why?
|
| Aspergillus fumigatus | 2 | 2013 | 44 | 0.050 |
Why?
|
| Drug Compounding | 2 | 2013 | 42 | 0.050 |
Why?
|
| Neutrophils | 1 | 2005 | 360 | 0.050 |
Why?
|
| Ascomycota | 2 | 2013 | 26 | 0.050 |
Why?
|
| Disclosure | 1 | 2024 | 152 | 0.050 |
Why?
|
| North America | 1 | 2004 | 265 | 0.050 |
Why?
|
| Communication | 1 | 2007 | 542 | 0.050 |
Why?
|
| Injections, Spinal | 2 | 2013 | 135 | 0.050 |
Why?
|
| Peritonitis | 3 | 2013 | 76 | 0.050 |
Why?
|
| Pain Measurement | 2 | 2015 | 355 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2010 | 888 | 0.050 |
Why?
|
| Linear Models | 2 | 2019 | 713 | 0.050 |
Why?
|
| Diet | 1 | 2009 | 1125 | 0.050 |
Why?
|
| Referral and Consultation | 2 | 2018 | 569 | 0.050 |
Why?
|
| Pain | 1 | 1985 | 457 | 0.050 |
Why?
|
| Physician's Role | 1 | 2024 | 169 | 0.050 |
Why?
|
| Biopsy | 3 | 2015 | 1284 | 0.050 |
Why?
|
| Hypertension | 3 | 2019 | 1396 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2014 | 3412 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 2016 | 590 | 0.050 |
Why?
|
| Data Collection | 1 | 2004 | 391 | 0.050 |
Why?
|
| Menarche | 2 | 2011 | 35 | 0.050 |
Why?
|
| Streptococcus pneumoniae | 1 | 2004 | 381 | 0.050 |
Why?
|
| Ovarian Diseases | 2 | 2011 | 25 | 0.050 |
Why?
|
| Adnexal Diseases | 2 | 2011 | 23 | 0.040 |
Why?
|
| Torsion Abnormality | 2 | 2011 | 36 | 0.040 |
Why?
|
| Disasters | 2 | 2012 | 106 | 0.040 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2004 | 382 | 0.040 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2011 | 91 | 0.040 |
Why?
|
| Social Support | 1 | 2024 | 387 | 0.040 |
Why?
|
| Hospitals, Teaching | 2 | 2011 | 113 | 0.040 |
Why?
|
| Canada | 2 | 2020 | 337 | 0.040 |
Why?
|
| Acute Kidney Injury | 1 | 2008 | 670 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2004 | 479 | 0.040 |
Why?
|
| Peptide Fragments | 2 | 2015 | 800 | 0.040 |
Why?
|
| Disposable Equipment | 1 | 2020 | 18 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 2 | 2019 | 576 | 0.040 |
Why?
|
| Textiles | 1 | 2020 | 11 | 0.040 |
Why?
|
| Databases, Factual | 3 | 2016 | 1230 | 0.040 |
Why?
|
| Bibliometrics | 1 | 2020 | 37 | 0.040 |
Why?
|
| Adenoviridae | 2 | 1999 | 596 | 0.040 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2020 | 81 | 0.040 |
Why?
|
| Organizational Policy | 1 | 2020 | 54 | 0.040 |
Why?
|
| Survival Rate | 3 | 2020 | 2188 | 0.040 |
Why?
|
| DNA, Recombinant | 1 | 1999 | 72 | 0.040 |
Why?
|
| Antitubercular Agents | 1 | 2002 | 264 | 0.040 |
Why?
|
| Pharynx | 1 | 1999 | 66 | 0.040 |
Why?
|
| Cytidine Deaminase | 1 | 1999 | 32 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 1457 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2019 | 51 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2019 | 24 | 0.040 |
Why?
|
| Glucose | 1 | 2023 | 870 | 0.040 |
Why?
|
| Constipation | 1 | 2000 | 128 | 0.040 |
Why?
|
| Office Visits | 1 | 2019 | 78 | 0.040 |
Why?
|
| Pneumoperitoneum | 2 | 2005 | 10 | 0.040 |
Why?
|
| Hypertrophy | 1 | 1999 | 101 | 0.040 |
Why?
|
| Emergencies | 1 | 2000 | 186 | 0.040 |
Why?
|
| Ferritins | 1 | 2019 | 109 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2005 | 814 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 315 | 0.040 |
Why?
|
| Foreign-Body Migration | 1 | 2018 | 60 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 1999 | 1033 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2013 | 305 | 0.030 |
Why?
|
| Antigens, CD19 | 1 | 2019 | 183 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2013 | 240 | 0.030 |
Why?
|
| Urinary Tract | 1 | 2018 | 63 | 0.030 |
Why?
|
| Surgical Stomas | 1 | 2017 | 10 | 0.030 |
Why?
|
| Anthropometry | 1 | 2018 | 194 | 0.030 |
Why?
|
| Vitamin D | 1 | 2019 | 183 | 0.030 |
Why?
|
| Recurrence | 2 | 2014 | 1453 | 0.030 |
Why?
|
| Barium | 1 | 1997 | 17 | 0.030 |
Why?
|
| Crohn Disease | 1 | 2000 | 291 | 0.030 |
Why?
|
| Equipment Failure | 1 | 2017 | 136 | 0.030 |
Why?
|
| Necrosis | 1 | 2017 | 209 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2012 | 338 | 0.030 |
Why?
|
| Professional Practice Location | 1 | 2016 | 8 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 258 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 686 | 0.030 |
Why?
|
| Catheter-Related Infections | 1 | 2018 | 136 | 0.030 |
Why?
|
| Renal Veins | 1 | 1996 | 34 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 328 | 0.030 |
Why?
|
| Urban Health Services | 1 | 2016 | 21 | 0.030 |
Why?
|
| Vulva | 1 | 2016 | 16 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 1996 | 144 | 0.030 |
Why?
|
| Birth Weight | 2 | 2010 | 350 | 0.030 |
Why?
|
| Cholesterol | 1 | 1999 | 558 | 0.030 |
Why?
|
| Leukocytosis | 1 | 1996 | 48 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 800 | 0.030 |
Why?
|
| Rural Health Services | 1 | 2016 | 27 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 1996 | 94 | 0.030 |
Why?
|
| Metformin | 1 | 2018 | 166 | 0.030 |
Why?
|
| Leukemia, Myeloid | 1 | 1996 | 81 | 0.030 |
Why?
|
| Thrombosis | 2 | 2002 | 523 | 0.030 |
Why?
|
| Injections | 1 | 1996 | 152 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2019 | 425 | 0.030 |
Why?
|
| Risk | 1 | 1997 | 761 | 0.030 |
Why?
|
| Endodermal Sinus Tumor | 1 | 1995 | 7 | 0.030 |
Why?
|
| Patient Selection | 2 | 2013 | 732 | 0.030 |
Why?
|
| Dimerization | 1 | 2015 | 149 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2015 | 275 | 0.030 |
Why?
|
| Peptide YY | 1 | 2015 | 19 | 0.030 |
Why?
|
| Chronic Disease | 3 | 2012 | 1234 | 0.030 |
Why?
|
| Serum Amyloid A Protein | 1 | 2015 | 44 | 0.030 |
Why?
|
| Operative Time | 1 | 2016 | 192 | 0.030 |
Why?
|
| DNA Probes | 1 | 1995 | 124 | 0.030 |
Why?
|
| Physical Fitness | 1 | 2015 | 91 | 0.030 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1995 | 64 | 0.030 |
Why?
|
| Angiography | 2 | 1993 | 208 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2016 | 327 | 0.030 |
Why?
|
| Hospitals, Community | 1 | 2015 | 55 | 0.030 |
Why?
|
| Basal Metabolism | 1 | 2015 | 93 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2015 | 1400 | 0.030 |
Why?
|
| Life Style | 1 | 2017 | 453 | 0.030 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2014 | 33 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2015 | 146 | 0.030 |
Why?
|
| Adipokines | 1 | 2015 | 77 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2015 | 351 | 0.030 |
Why?
|
| Wound Infection | 2 | 2012 | 56 | 0.030 |
Why?
|
| Probability | 2 | 2008 | 322 | 0.030 |
Why?
|
| Lipids | 1 | 2018 | 561 | 0.030 |
Why?
|
| Dogs | 2 | 2012 | 652 | 0.030 |
Why?
|
| Pulsatile Flow | 1 | 2014 | 124 | 0.030 |
Why?
|
| alpha-Macroglobulins | 1 | 2014 | 6 | 0.030 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2014 | 16 | 0.030 |
Why?
|
| Xanthomonas | 1 | 1994 | 4 | 0.030 |
Why?
|
| Malassezia | 1 | 1994 | 7 | 0.030 |
Why?
|
| Albuminuria | 1 | 2014 | 112 | 0.030 |
Why?
|
| Hemothorax | 1 | 1994 | 20 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2018 | 482 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2014 | 138 | 0.030 |
Why?
|
| Teratoma | 1 | 1995 | 129 | 0.030 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2014 | 53 | 0.030 |
Why?
|
| Injections, Epidural | 1 | 2013 | 5 | 0.030 |
Why?
|
| Serpins | 1 | 2014 | 34 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2014 | 99 | 0.030 |
Why?
|
| Ischemia | 1 | 2017 | 370 | 0.030 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2013 | 17 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 2014 | 73 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2015 | 207 | 0.030 |
Why?
|
| Rats | 2 | 1999 | 3606 | 0.030 |
Why?
|
| Forecasting | 1 | 2015 | 372 | 0.030 |
Why?
|
| Leptin | 1 | 2015 | 219 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2014 | 144 | 0.030 |
Why?
|
| Jejunal Neoplasms | 1 | 2013 | 5 | 0.030 |
Why?
|
| Neoplasms, Adipose Tissue | 1 | 2013 | 8 | 0.030 |
Why?
|
| Video Games | 1 | 2015 | 98 | 0.030 |
Why?
|
| Hospital Bed Capacity | 1 | 2013 | 28 | 0.030 |
Why?
|
| Malnutrition | 1 | 2015 | 161 | 0.030 |
Why?
|
| Hydrocodone | 1 | 2013 | 37 | 0.030 |
Why?
|
| Cystatin C | 1 | 2014 | 74 | 0.030 |
Why?
|
| Intestinal Polyps | 1 | 2013 | 29 | 0.030 |
Why?
|
| Morphine | 1 | 2013 | 85 | 0.030 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2013 | 28 | 0.030 |
Why?
|
| Abdominal Abscess | 1 | 2013 | 27 | 0.030 |
Why?
|
| Liposarcoma | 1 | 2013 | 23 | 0.030 |
Why?
|
| Infectious Disease Incubation Period | 1 | 2012 | 9 | 0.020 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2013 | 40 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 88 | 0.020 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2013 | 35 | 0.020 |
Why?
|
| Missouri | 1 | 2012 | 42 | 0.020 |
Why?
|
| Pleural Effusion | 1 | 1994 | 110 | 0.020 |
Why?
|
| DNA, Ribosomal | 1 | 2012 | 57 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 286 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 1997 | 356 | 0.020 |
Why?
|
| Extremities | 1 | 1993 | 82 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2013 | 309 | 0.020 |
Why?
|
| Symptom Assessment | 1 | 2013 | 111 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2015 | 241 | 0.020 |
Why?
|
| Rho(D) Immune Globulin | 1 | 2012 | 12 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2014 | 239 | 0.020 |
Why?
|
| DNA, Fungal | 1 | 2012 | 76 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2014 | 237 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2013 | 167 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2007 | 956 | 0.020 |
Why?
|
| Tertiary Care Centers | 1 | 2013 | 256 | 0.020 |
Why?
|
| Thoracic Injuries | 1 | 1993 | 90 | 0.020 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2013 | 79 | 0.020 |
Why?
|
| Acetaminophen | 1 | 2013 | 97 | 0.020 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2013 | 84 | 0.020 |
Why?
|
| Eye Proteins | 1 | 2014 | 232 | 0.020 |
Why?
|
| Bites and Stings | 1 | 2012 | 29 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2013 | 119 | 0.020 |
Why?
|
| Cell Movement | 1 | 1996 | 888 | 0.020 |
Why?
|
| Isoantibodies | 1 | 2012 | 58 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 356 | 0.020 |
Why?
|
| Wounds, Stab | 1 | 1992 | 36 | 0.020 |
Why?
|
| Pseudomonas Infections | 1 | 2013 | 116 | 0.020 |
Why?
|
| Focus Groups | 1 | 2013 | 224 | 0.020 |
Why?
|
| Body Composition | 1 | 2015 | 550 | 0.020 |
Why?
|
| Patient Transfer | 1 | 2013 | 110 | 0.020 |
Why?
|
| Mice | 4 | 2019 | 18478 | 0.020 |
Why?
|
| Drug Costs | 1 | 2012 | 65 | 0.020 |
Why?
|
| Mesenteric Cyst | 1 | 1991 | 3 | 0.020 |
Why?
|
| Ectromelia | 1 | 1991 | 4 | 0.020 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2019 | 899 | 0.020 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 1991 | 10 | 0.020 |
Why?
|
| Hirsutism | 1 | 2011 | 24 | 0.020 |
Why?
|
| Arteries | 1 | 1993 | 221 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 826 | 0.020 |
Why?
|
| Diverticulitis | 1 | 1991 | 8 | 0.020 |
Why?
|
| Swine | 1 | 2015 | 1178 | 0.020 |
Why?
|
| Anemia, Hemolytic | 1 | 2011 | 32 | 0.020 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 1991 | 32 | 0.020 |
Why?
|
| Thoracic Surgery | 1 | 1994 | 166 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 679 | 0.020 |
Why?
|
| Multiple Trauma | 1 | 1992 | 63 | 0.020 |
Why?
|
| Jaundice | 1 | 2011 | 27 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2012 | 150 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 2509 | 0.020 |
Why?
|
| Intestinal Neoplasms | 1 | 1991 | 40 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 2013 | 148 | 0.020 |
Why?
|
| Contrast Media | 1 | 2015 | 507 | 0.020 |
Why?
|
| Perioperative Care | 1 | 2013 | 211 | 0.020 |
Why?
|
| Hamartoma | 1 | 1991 | 52 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 879 | 0.020 |
Why?
|
| Immunosuppressive Agents | 2 | 2012 | 673 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 588 | 0.020 |
Why?
|
| Wound Healing | 1 | 1995 | 476 | 0.020 |
Why?
|
| Respiration Disorders | 1 | 1991 | 33 | 0.020 |
Why?
|
| Hospital Costs | 1 | 2012 | 187 | 0.020 |
Why?
|
| Premature Birth | 1 | 2015 | 418 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2014 | 503 | 0.020 |
Why?
|
| Hemoperitoneum | 1 | 1990 | 10 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2013 | 393 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 313 | 0.020 |
Why?
|
| Hemangioma | 1 | 1991 | 97 | 0.020 |
Why?
|
| Public Health | 1 | 2012 | 281 | 0.020 |
Why?
|
| Colonic Diseases | 1 | 1990 | 38 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2014 | 489 | 0.020 |
Why?
|
| Insulin | 1 | 2015 | 1168 | 0.020 |
Why?
|
| Skin | 1 | 2012 | 527 | 0.020 |
Why?
|
| Age Determination by Skeleton | 1 | 2009 | 11 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1991 | 237 | 0.020 |
Why?
|
| Adrenarche | 1 | 2009 | 11 | 0.020 |
Why?
|
| Pancreatitis | 1 | 1990 | 140 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 2679 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 1993 | 416 | 0.020 |
Why?
|
| Visual Fields | 1 | 2010 | 144 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 471 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1991 | 377 | 0.020 |
Why?
|
| Intracranial Pressure | 1 | 2010 | 212 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2000 | 1859 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2010 | 357 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 1995 | 4757 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2015 | 898 | 0.020 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2007 | 11 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1882 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2008 | 143 | 0.020 |
Why?
|
| Blood Vessels | 1 | 1988 | 103 | 0.020 |
Why?
|
| Adrenalectomy | 1 | 2007 | 40 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1285 | 0.020 |
Why?
|
| Morbidity | 1 | 2008 | 256 | 0.020 |
Why?
|
| Fever | 1 | 1990 | 310 | 0.020 |
Why?
|
| Leg | 1 | 1988 | 133 | 0.020 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2006 | 20 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2442 | 0.020 |
Why?
|
| South Africa | 1 | 2006 | 108 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 4710 | 0.020 |
Why?
|
| Mortality | 1 | 2008 | 263 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2013 | 1099 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2010 | 606 | 0.020 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2006 | 111 | 0.020 |
Why?
|
| Vagotomy | 1 | 2005 | 10 | 0.010 |
Why?
|
| Peptic Ulcer Perforation | 1 | 2005 | 15 | 0.010 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2005 | 20 | 0.010 |
Why?
|
| Gastric Outlet Obstruction | 1 | 2005 | 15 | 0.010 |
Why?
|
| Pyloric Antrum | 1 | 2005 | 62 | 0.010 |
Why?
|
| Vomiting | 1 | 1985 | 108 | 0.010 |
Why?
|
| Wounds, Gunshot | 1 | 1986 | 145 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2008 | 504 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2008 | 485 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2006 | 285 | 0.010 |
Why?
|
| Surface Tension | 1 | 2004 | 6 | 0.010 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2004 | 6 | 0.010 |
Why?
|
| Drug Resistance, Fungal | 1 | 2004 | 30 | 0.010 |
Why?
|
| Mental Competency | 1 | 2004 | 53 | 0.010 |
Why?
|
| Safety | 1 | 2004 | 216 | 0.010 |
Why?
|
| Nutritional Requirements | 1 | 2004 | 160 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 2004 | 230 | 0.010 |
Why?
|
| Cholestasis | 1 | 2005 | 157 | 0.010 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2002 | 86 | 0.010 |
Why?
|
| Echocardiography | 1 | 2008 | 1124 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1999 | 1350 | 0.010 |
Why?
|
| Biological Products | 1 | 2004 | 137 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 923 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2002 | 364 | 0.010 |
Why?
|
| Omentum | 1 | 2001 | 47 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1991 | 1381 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2004 | 827 | 0.010 |
Why?
|
| Heart Rate | 1 | 2004 | 584 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2004 | 429 | 0.010 |
Why?
|
| Megacolon | 1 | 2000 | 4 | 0.010 |
Why?
|
| Fallopian Tubes | 1 | 2001 | 76 | 0.010 |
Why?
|
| Hirschsprung Disease | 1 | 2000 | 38 | 0.010 |
Why?
|
| APOBEC-1 Deaminase | 1 | 1999 | 12 | 0.010 |
Why?
|
| Graft Survival | 2 | 1992 | 473 | 0.010 |
Why?
|
| Age of Onset | 1 | 2001 | 622 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1999 | 274 | 0.010 |
Why?
|
| Colitis | 1 | 2000 | 165 | 0.010 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2000 | 335 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 1999 | 239 | 0.010 |
Why?
|
| Daunorubicin | 1 | 1996 | 27 | 0.010 |
Why?
|
| Thioguanine | 1 | 1996 | 22 | 0.010 |
Why?
|
| Leukapheresis | 1 | 1996 | 14 | 0.010 |
Why?
|
| Cytarabine | 1 | 1996 | 102 | 0.010 |
Why?
|
| Atrophy | 1 | 1996 | 251 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 1996 | 186 | 0.010 |
Why?
|
| Sacrococcygeal Region | 1 | 1995 | 36 | 0.010 |
Why?
|
| Autopsy | 1 | 1995 | 117 | 0.010 |
Why?
|
| Diatrizoate Meglumine | 1 | 1993 | 18 | 0.010 |
Why?
|
| Carbocyanines | 1 | 1992 | 10 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1992 | 68 | 0.010 |
Why?
|
| Sheep | 1 | 1992 | 229 | 0.010 |
Why?
|
| Thoracotomy | 1 | 1993 | 110 | 0.010 |
Why?
|
| Aging | 1 | 1999 | 1249 | 0.010 |
Why?
|
| Premedication | 1 | 1991 | 42 | 0.010 |
Why?
|
| Lung Injury | 1 | 1993 | 123 | 0.010 |
Why?
|
| Causality | 1 | 1991 | 94 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1991 | 196 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1992 | 326 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1992 | 264 | 0.010 |
Why?
|
| Kanamycin Kinase | 1 | 1991 | 16 | 0.010 |
Why?
|
| Duodenal Obstruction | 1 | 1990 | 14 | 0.010 |
Why?
|
| Phosphotransferases | 1 | 1991 | 40 | 0.010 |
Why?
|
| Retroviridae | 1 | 1991 | 194 | 0.010 |
Why?
|
| Barium Sulfate | 1 | 1990 | 14 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1992 | 801 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1991 | 448 | 0.010 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 1990 | 21 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 1991 | 294 | 0.000 |
Why?
|
| Clinical Protocols | 1 | 1991 | 239 | 0.000 |
Why?
|
| Saphenous Vein | 1 | 1988 | 53 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1991 | 1177 | 0.000 |
Why?
|
| Feasibility Studies | 1 | 1991 | 819 | 0.000 |
Why?
|
| Anemia | 1 | 1991 | 350 | 0.000 |
Why?
|
| Transplantation, Autologous | 1 | 1988 | 286 | 0.000 |
Why?
|
| Aneurysm | 1 | 1988 | 82 | 0.000 |
Why?
|
| Jejunal Diseases | 1 | 1986 | 13 | 0.000 |
Why?
|
| Pancreatic Fistula | 1 | 1986 | 30 | 0.000 |
Why?
|
| Intestinal Fistula | 1 | 1986 | 29 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1991 | 1160 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1990 | 797 | 0.000 |
Why?
|
| Abnormalities, Multiple | 1 | 1990 | 981 | 0.000 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1988 | 515 | 0.000 |
Why?
|